518 related articles for article (PubMed ID: 24929655)
1. Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.
Vendel E; de Lange EC
Neuromolecular Med; 2014 Sep; 16(3):620-42. PubMed ID: 24929655
[TBL] [Abstract][Full Text] [Related]
2. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
3. The seek of neuroprotection: introducing cannabinoids.
Martínez-Orgado J; Fernández-López D; Lizasoain I; Romero J
Recent Pat CNS Drug Discov; 2007 Jun; 2(2):131-9. PubMed ID: 18221224
[TBL] [Abstract][Full Text] [Related]
4. Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors.
Mestre L; Iñigo PM; Mecha M; Correa FG; Hernangómez-Herrero M; Loría F; Docagne F; Borrell J; Guaza C
J Neuroinflammation; 2011 Aug; 8():102. PubMed ID: 21851608
[TBL] [Abstract][Full Text] [Related]
5. The multiplicity of action of cannabinoids: implications for treating neurodegeneration.
Gowran A; Noonan J; Campbell VA
CNS Neurosci Ther; 2011 Dec; 17(6):637-44. PubMed ID: 20875047
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride E
Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
[TBL] [Abstract][Full Text] [Related]
7. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Kokona D; Thermos K
Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors.
Scutt A; Williamson EM
Calcif Tissue Int; 2007 Jan; 80(1):50-9. PubMed ID: 17205329
[TBL] [Abstract][Full Text] [Related]
9. Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.
Valdeolivas S; Satta V; Pertwee RG; Fernández-Ruiz J; Sagredo O
ACS Chem Neurosci; 2012 May; 3(5):400-6. PubMed ID: 22860209
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid signalling.
Demuth DG; Molleman A
Life Sci; 2006 Jan; 78(6):549-63. PubMed ID: 16109430
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological actions of cannabinoids.
Pertwee RG
Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.
McHugh D; Tanner C; Mechoulam R; Pertwee RG; Ross RA
Mol Pharmacol; 2008 Feb; 73(2):441-50. PubMed ID: 17965195
[TBL] [Abstract][Full Text] [Related]
13. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
[TBL] [Abstract][Full Text] [Related]
14. The cannabinoid system and immune modulation.
Klein TW; Newton C; Larsen K; Lu L; Perkins I; Nong L; Friedman H
J Leukoc Biol; 2003 Oct; 74(4):486-96. PubMed ID: 12960289
[TBL] [Abstract][Full Text] [Related]
15. Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro.
Harvey BS; Ohlsson KS; Mååg JL; Musgrave IF; Smid SD
Neurotoxicology; 2012 Jan; 33(1):138-46. PubMed ID: 22233683
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system in amyotrophic lateral sclerosis.
Bilsland LG; Greensmith L
Curr Pharm Des; 2008; 14(23):2306-16. PubMed ID: 18781981
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus.
Andó RD; Bíró J; Csölle C; Ledent C; Sperlágh B
Neurochem Int; 2012 Jan; 60(2):145-52. PubMed ID: 22133429
[TBL] [Abstract][Full Text] [Related]
18. Regulation of hematopoietic stem cell trafficking and mobilization by the endocannabinoid system.
Jiang S; Fu Y; Avraham HK
Transfusion; 2011 Nov; 51 Suppl 4():65S-71S. PubMed ID: 22074629
[TBL] [Abstract][Full Text] [Related]
19. Differential cannabinoid receptor expression during reactive gliosis: a possible implication for a nonpsychotropic neuroprotection.
De Filippis D; Steardo A; D'Amico A; Scuderi C; Cipriano M; Esposito G; Iuvone T
ScientificWorldJournal; 2009 Mar; 9():229-35. PubMed ID: 19347234
[TBL] [Abstract][Full Text] [Related]
20. Stearoylethanolamide interferes with retrograde endocannabinoid signalling and supports the blood-brain barrier integrity under acute systemic inflammation.
Kasatkina LA; Heinemann A; Hudz YA; Thomas D; Sturm EM
Biochem Pharmacol; 2020 Apr; 174():113783. PubMed ID: 31881191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
